Come up with a name for your new list and we'll add to it:
SynapDx raised a round of funding on March 27, 2013. Investors include
The Kraft Group.
SynapDx is an early stage laboratory services company developing a blood based test to enable earlier detection of Autism Spectrum Disorders (ASDs). ASDs are characterized by impairment in language an…